Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lululemon Athletica | LULU | Aug 30, 2024 | 259.47 | +0.18 |
Lulus Fashion Lounge | LVLU | Aug 30, 2024 | 1.42 | +6.60 |
Lumen Technologies | LUMN | Aug 30, 2024 | 5.25 | +1.55 |
Lument Finance Trust | LFT | Aug 30, 2024 | 2.46 | -0.40 |
Lument Finance Trust A Pref | LFT-A | Aug 30, 2024 | 21.34 | +2.36 |
Lumentum | LITE | Aug 30, 2024 | 57.61 | +1.91 |
Luminar Technologies A | LAZR | Aug 30, 2024 | 1.02 | 0.00 |
Lumos Pharma | LUMO | Aug 30, 2024 | 3.90 | -0.26 |
Luna Innovations | LUNA | Aug 30, 2024 | 2.38 | 0.00 |
Luokung Technology | LKCO | Aug 30, 2024 | 0.66 | +1.95 |
Luxfer | LXFR | Aug 30, 2024 | 11.22 | +3.22 |
LuxUrban Hotels | LUXH | Aug 30, 2024 | 0.08 | +3.72 |
Luxurban Hotels Pref | LUXHP | Aug 30, 2024 | 15.25 | +5.10 |
Lxp Industrial Trust | LXP | Aug 30, 2024 | 10.36 | +0.88 |
LXP Industrial Trust C Pref | LXP-C | Aug 30, 2024 | 48.98 | +0.78 |
Lyell Immunopharma | LYEL | Aug 30, 2024 | 1.45 | -0.68 |
Lyft A | LYFT | Aug 30, 2024 | 11.67 | +1.04 |
LyondellBasell Industries Nv A | LYB | Aug 30, 2024 | 98.70 | +0.54 |
Lyra Therapeutics | LYRA | Aug 30, 2024 | 0.32 | +2.00 |
Lytus Technologies | LYT | Aug 30, 2024 | 1.76 | -2.22 |
M&T Bank | MTB | Aug 30, 2024 | 172.11 | +1.25 |
M&T Bank ADR Prej J | MTB-J | Aug 30, 2024 | 27.09 | +0.33 |
M&T Bank H Pref | MTB-H | Aug 30, 2024 | 25.32 | -0.12 |
M-tron Industries | MPTI | Aug 30, 2024 | 37.51 | +1.85 |
M/I Homes | MHO | Aug 30, 2024 | 159.37 | +0.71 |
M3-Brigade Acquisition V | MBAVU | Aug 30, 2024 | 10.02 | 0.00 |
Macatawa Bank | MCBC | Aug 30, 2024 | 14.82 | 0.00 |
Macerich | MAC | Aug 30, 2024 | 15.97 | +2.18 |
Mach Natural Resources LP | MNR | Aug 30, 2024 | 19.32 | +1.20 |
MACOM Technology Solutions | MTSI | Aug 30, 2024 | 109.23 | -0.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.